228 related articles for article (PubMed ID: 27494889)
1. Stathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinoma.
Yurong L; Biaoxue R; Wei L; Zongjuan M; Hongyang S; Ping F; Wenlong G; Shuanying Y; Zongfang L
Oncotarget; 2017 Apr; 8(16):26000-26012. PubMed ID: 27494889
[TBL] [Abstract][Full Text] [Related]
2. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
Rong B; Nan Y; Liu H; Gao W
Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
[TBL] [Abstract][Full Text] [Related]
3. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma.
Yuan W; Zhang X; Xu Y; Li S; Hu Y; Wu S
Mol Carcinog; 2014 Jan; 53(1):49-57. PubMed ID: 22911672
[TBL] [Abstract][Full Text] [Related]
4. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
5. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells.
Lv FZ; Wang JL; Wu Y; Chen HF; Shen XY
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):77-84. PubMed ID: 25816409
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
8. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
[TBL] [Abstract][Full Text] [Related]
9. STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.
Akhtar J; Wang Z; Yu C; Li CS; Shi YL; Liu HJ
BMC Cancer; 2014 Jan; 14():28. PubMed ID: 24433541
[TBL] [Abstract][Full Text] [Related]
10. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
12. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
13. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y
Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
17. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
Shen QM; Wang HY; Xu S
Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression.
Zeng Q; Li S; Zhou Y; Ou W; Cai X; Zhang L; Huang W; Huang L; Wang Q
Cytokine; 2014 Jan; 65(1):24-32. PubMed ID: 24140068
[TBL] [Abstract][Full Text] [Related]
19. PKCζ, MMP‑2 and MMP‑9 expression in lung adenocarcinoma and association with a metastatic phenotype.
Cai X; Zhu H; Li Y
Mol Med Rep; 2017 Dec; 16(6):8301-8306. PubMed ID: 28983601
[TBL] [Abstract][Full Text] [Related]
20. Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma.
Cai XD; Che L; Lin JX; Huang S; Li J; Liu XY; Pan XF; Wang QQ; Chen L; Lin MJ; Huang ZH; Ma HM; Wu Y; Liu SM; Zhou YB
Oncotarget; 2017 Jun; 8(24):38743-38754. PubMed ID: 28454121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
